SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharply reduced third-quarter outlook, driven by weak demand, excess distributor inventory and a major pricing reset, has intensified concerns about its business and heavy debt. Traders are divided between viewing the reset and debt-reduction measures as a path to recovery and fearing further deterioration or bankruptcy.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Speculation that Johnson & Johnson could acquire Sellas Life Sciences is a recurring topic, with traders pointing to alleged executive connections and J&Js oncology ambitions; no deal has been confirmed. Traders are also debating J&Js earnings reaction: stronger-than-expected results and raised guidance were offset by weak MedTech growth and litigation concerns, while some view the pullback as a buying opportunity.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Discussion centers on whether Teladoc can show a credible turnaround in its quarterly results, especially stabilizing BetterHelp as it shifts from cash-pay to insurance amid concerns about declining revenue, profitability and management execution. Bulls cite potential insurance growth, Teladoc One and short-interest dynamics, while skeptics remain doubtful; squeeze claims are speculative.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Discussion centers on Lillys obesity and diabetes franchise and expectations for quarterly results, with traders pointing to Mounjaro and Zepbound demand, Foundayo uptake, and pipeline prospects. Bulls cite growth and healthcare-sector strength, while skeptics flag Lillys high valuation and competition from Novo Nordisk and emerging obesity-drug rivals.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens attention is centered on Phase 3 results showing IMDELLTRA with AstraZenecas IMFINZI reduced the risk of death in first-line extensive-stage small-cell lung cancer. Traders are treating the survival findings as a positive oncology catalyst, while some also point to favorable Phase 3 TEZSPIRE results in eosinophilic esophagitis.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

Speculation about a potential AstraZenecaBristol Myers Squibb merger has drawn attention, with traders debating the deals strategic value and financial risks. Reports that no discussions took place cooled the rumor, though some community members remain skeptical.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is drawing attention ahead of its fiscal-year earnings report, with traders focused on margin and forward guidance rather than a likely headline beat. Sentiment is split between bullish momentum near record highs and concerns that expectations are stretched, with some traders watching for a post-report pullback.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

A sharp pullback in semiconductor stocks has put SMH at the center of a debate over whether worries about AI spending, financing and chip-sector valuations signal a deeper downturn. Traders are split between expecting more downside and looking for an oversold bounce, with some arguing that strong AI demand and continued capital spending support the longer-term outlook.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

The ongoing shale-oil antitrust case is drawing attention after the judge deferred jurisdictional rulings for Hess and Pioneer pending limited discovery, with an October status conference ahead; traders emphasize that the claims remain unresolved. Bullish chatter also points to oil-linked strength and a possible technical breakout, though some traders are watching resistance.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms planned performance-focused global layoffs are drawing attention, with traders divided over whether the restructuring signals tighter cost discipline or reflects underperformance. The discussion also centers on the stock holding up relatively well against semiconductor peers and whether the upcoming earnings report will validate a rebound, while skeptics remain wary of its recent weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stocktwits Space Race Weekly: RKLB, VSAT Beat SPCX With Modest Gains — ASTS And PL Sink Deeper 

Equity

SpaceX continued Tesla merger talks and is reportedly exploring access to 80,000 U.S. cellular sites for a potential nationwide wireless network.

RKLB Stock Edges Up Overnight As SpaceX Passes On 3 Military Missions; Rocket Lab Speeds Up Testing

SpaceX reportedly passed on three military satellite launches, with no rival bids, highlighting the Pentagon’s limited launch options.

RKLB Is Among Nasdaq’s Top 5 Losers So Far This Month, Yet Analysts See 90% Upside — Can Neutron Justify Its SpaceX Premium? 

RKLB trades at 26.6x forward EV/sales, about 89% above SpaceX, while Redwire has the lowest valuation multiples.

RKLB Stock Jumps Overnight: Rocket Lab Is About To Attempt A Mars Maneuver That’s Never Worked Before

The NASA mission is expected to reach Mars in September next year to study how solar wind strips away its upper atmosphere.

RKLB Stock Dips Overnight: Rocket Lab Shows Neutron Progress After 2027 Delay, But Retail Wants Dates And Deals

Rocket Lab is manufacturing a replacement forward dome for Neutron’s first-stage propellant tank.

RKLB Stock Suffers Worst Week Ever: AST SpaceMobile Partner Challenges Iridium Deal — Claims Rival Uses FCC To Block Competitors 

 Ligado accused Iridium of using regulatory filings to obstruct competitors, including its SkyTerra Next service with AST SpaceMobile.

Stocktwits Space Race Weekly: SPCX Weathers Selloff Better Than ASTS, RKLB And FLY — RDW Fares Best 

SpaceX faced Ukraine-related satellite-service scrutiny as Barclays’ merger speculation and the flying Roadster revealed renewed attention on its Tesla ties.

Did ASTS Miss Its Rocket Lab Moment? Analyst Warns Deal Window May Be Closing, Floats Firefly As A Target 

Analyst Tim Farrar also questioned AST’s launch capacity for a midband constellation.

RKLB Stock’s Slide Hits Day 7: Cathie Wood’s ARK Buys The Dip As Rocket Lab Touts Mars Record Amid Neutron Delay 

Rocket Lab highlighted its hardware’s role in Perseverance’s record-setting 28.1-mile journey on Mars.

Rocket Lab Retail Mood Hits All-Time Low After Neutron Delay — Can Takeover Target Iridium’s Earnings Turn The Tide? 

Iridium would more than double Rocket Lab’s revenue base based on its 2025 results and bring a profitable business.

Tidal Trust II - Defiance Daily Target 2X Long RKLB ETF

Bullish Sentiment

<ul class="summary-bullets"><li>Rocket Lab plans to double testing capacity and cut stack-test times to under a day, supporting over 100 launches in backlog.</li><li>Viasat advanced NASA communications demo after Maxwell’s launch and challenged AST SpaceMobile’s overseas spectrum request at the FCC.</li><li>Planet launched Pelican-12 and secured a NASA evaluation task order covering more than 250,000 square kilometers of Tanager hyperspectral data.</li></ul>Rocket Lab (RKLB) and Viasat (VSAT) edged ahead of <a class="mention" data-mention="$SPCX" data-symbol-id="SPCX" href="https://stocktwits.com/symbol/SPCX" target="_blank">SpaceX</a> (SPCX) in this week’s space-stock race, holding modest gains as Elon Musk’s company slipped despite surging revenue and Tesla merger talks, while AST SpaceMobile (ASTS) and Planet Labs (PL) suffered deeper losses.So far this week, RKLB has gained 0.8% and VSAT has edged up 0.3%, outperforming SPCX’s 0.9% decline. ASTS has led losses with a 4.7% drop, while PL has fallen 3.5%.&nbsp;<img src="https://news.stocktwits-cdn.com/space_weekly_b4080821b3.png" alt="space weekly.png"><h2 class="st-heading-2">SPCX Slips As Earnings And Merger Buzz Build</h2>SpaceX reported on Tuesday that revenue surged 161% to $14.58 billion from a year ago, with net income reaching $4.4 billion. Its AI business generated $7.56 billion in revenue, while Starlink subscribers reached 13.6 million.Musk also&nbsp;weighed in on formal Tesla merger discussions through independent committees. “I think it would be a good idea, but it's really up to the special committees of both companies,” he said.&nbsp;The potential merger is still unsettled. SpaceX disclosed on Thursday that any transaction would require approval from its special committee, board and controlling shareholder, despite Musk’s recusal from negotiations because of conflicts of interest.&nbsp;Meanwhile, SpaceX is reportedly discussing access to at least 80,000 U.S. cellular sites as it explores building a fourth nationwide wireless carrier. TD Cowen estimated that such a terrestrial network could cost more than $80 billion.On Stocktwits, SPCX sentiment climbed to ‘extremely bullish’ from ‘bearish’ a week ago amid ‘extremely high’ message volume. Shares ended Thursday about 7% above their $135 June IPO price.<h2 class="st-heading-2">Rocket Lab Tops Peers As Launch Backlog Grows</h2>Rocket Lab led the group of space stocks this week as it outlined plans to increase capacity for its existing rockets, while advancing its delayed Neutron program.The company said that a new static-fire stack-test facility for Electron and HASTE would support more than 100 launches in backlog and a higher launch cadence in 2027. It expects to double testing capacity and cut stack-test time from two to three days to less than a day.“Demand for Electron and HASTE missions continues to grow and our manifest has never been busier,” Rocket Lab said. The company also launched Electron’s 98th mission on Friday. Rocket Lab also highlighted another spacecraft milestone: Maxwell, the satellite it built for Viasat, reached orbit Tuesday aboard SpaceX’s Bandwagon-5 mission.&nbsp;The week also underscored demand for alternative launch providers. SpaceX&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rklb-stock-spacex-passes-on-3-military-missions-rocket-lab-speeds-testing/cZxyTmcRBDt">reportedly</a> declined to bid on three future military satellite missions, and no rivals offered to take them on. That shortage could create an opening for Neutron, although Rocket Lab said that its debut would move into 2027.&nbsp;On Stocktwits, RKLB sentiment slipped to ‘bearish’ from ‘bullish’ a week ago amid ‘low’ message volume. Shares have declined about 27% year-to-date.&nbsp;<h2 class="st-heading-2">NASA Milestone And FCC Clash Put VSAT In Focus</h2>Viasat’s narrow gain came during a week spanning a spacecraft deployment and a regulatory clash with a satellite-connectivity rival. The company announced on Wednesday that Maxwell’s successful launch advanced work under two NASA Communications Services Project awards totaling $81 million. Five months of orbital demonstrations are planned through March 2027.Maxwell will test Ka-band and L-band relay services designed to keep low-Earth-orbit missions connected through Viasat’s satellites and ground network as NASA prepares to retire its Tracking and Data Relay Satellite fleet.Viasat also asked the Federal Communications Commission (FCC) to reject overseas spectrum authority sought by AST SpaceMobile, citing interference concerns and frequency-allocation restrictions.On Stocktwits, VSAT sentiment remained ‘bearish’ compared with a week ago amid ‘normal’ message volume. Shares have gained about 71% year-to-date.<h2 class="st-heading-2">ASTS Leads Losses Despite Coverage Push</h2>AST SpaceMobile was the group’s weakest performer despite fresh updates on commercial readiness and European cooperation.On Tuesday, AST targeted initial, intermittent coverage before year-end in the United States, Canada, Japan, UK and Saudi Arabia. It reported more than 60 gateways deployed, installed or in planning worldwide, supporting partnerships with over 60 mobile operators representing more than 3 billion subscribers.The company said more than 3,000 U.S. coverage cells were enabled and targeted 5,600 before year-end. Additional satellites would extend coverage duration as it works toward continuous service.&nbsp;A day earlier, AST welcomed Deutsche Telekom, Orange, Telefónica and Vodafone’s agreement to explore a joint European mobile-satellite spectrum bid. The initiative targets a market of more than 500 million mobile subscribers, though the carriers have yet to select a satellite provider.Viasat’s FCC challenge and SpaceX’s expanding wireless ambitions added competitive and regulatory questions. AST has said overseas operations would require national approvals and proposed technical measures to manage interference.&nbsp;On Stocktwits, ASTS sentiment slipped to ‘bearish’ from ‘bullish’ a week ago amid ‘normal’ message volume. Shares have declined about 47% year-to-date.<h2 class="st-heading-2">NASA Award And Satellite Launch Fail To Lift PL</h2>Meanwhile, Planet Labs underperformed SPCX even as it added a satellite and secured a NASA data-evaluation assignment.Pelican-12 launched on Tuesday aboard the same SpaceX Bandwagon-5 mission that carried Maxwell. Planet established contact and began commissioning the spacecraft, its fifth Pelican and 25th satellite launched in 2026.The second-gen satellite carries Nvidia Jetson tech for onboard AI processing and an SES Space &amp; Defense communications package to test faster imagery delivery through satellite-to-satellite relays. Gen 2 Pelicans are designed for imagery in the 30-centimeter class, compared with 50 centimeters for the first generation.&nbsp;On Wednesday, Planet announced a NASA Commercial Satellite Data Acquisition evaluation task order covering more than 250,000 square kilometers of Tanager hyperspectral data. NASA will assess its quality and usefulness for Earth science, including environmental monitoring and disaster response.On Stocktwits, PL sentiment slipped to ‘bearish’ from ‘neutral’ a week ago amid ‘low’ message volume. Shares have declined about 34% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/michael-burry-bumps-up-substack-subscription-price-4-busted-bear-market-havens/cZxyIwoRBxR">'Big Short' Investor Michael Burry Bumps Up Substack Subscription Price, Flags 4 'Busted' Bear-Market Havens&nbsp;</a>

A Smart Dragon-3 carrier rocket carrying the Oriental Smart Eye hyperspectral satellites 01 and 02 lifts off from the waters on August 5, 2026 in China. (Photo by Tang Ke/VCG via Getty Images)

Stocktwits Space Race Weekly: RKLB, VSAT Beat SPCX With Modest Gains — ASTS And PL Sink Deeper

Tidal Trust II - Defiance Daily Target 2X Short ASTS ETF

AST SpaceMobile Inc

Tidal Trust II - Defiance Daily Target 2X Long ASTS ETF

Tema Space Innovators ETF

Planet Labs PBC

Rocket Lab USA Inc

Defiance Daily Target 2X Long RKLB ETF

SpaceX

Viasat, Inc.

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

RKLX Defiance Daily Target 2X Long RKLB ETF

Fundamentals

Latest RKLX News